MRA Therapy
activeURL
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.29
Version20220716
PublisherAHA StewardDate2022-07-16T01:02:12-04:00Purpose(Clinical Focus: The purpose of this value set is to represent concepts of medications of mineralocorticoid receptor antagonists (MRA) therapy.),(Data Element Scope: This value set may use a model element related to Medication.),(Inclusion Criteria: Includes concepts that represent a medication for mineralocorticoid receptor antagonists (MRA) therapy.),(Exclusion Criteria: Excludes concepts that represent non-prescribable, branded drugs, components or ingredients.)
Expansion
| Code | Display | System |
|---|---|---|
| 198225 | http://www.nlm.nih.gov/research/umls/rxnorm | |
| 198223 | http://www.nlm.nih.gov/research/umls/rxnorm | |
| 2562824 | http://www.nlm.nih.gov/research/umls/rxnorm | |
| 104232 | http://www.nlm.nih.gov/research/umls/rxnorm | |
| 351257 | http://www.nlm.nih.gov/research/umls/rxnorm | |
| 198222 | http://www.nlm.nih.gov/research/umls/rxnorm | |
| 313096 | http://www.nlm.nih.gov/research/umls/rxnorm | |
| 351256 | http://www.nlm.nih.gov/research/umls/rxnorm | |
| 198224 | http://www.nlm.nih.gov/research/umls/rxnorm | |
| 2562816 | http://www.nlm.nih.gov/research/umls/rxnorm |